Isocorydine suppresses doxorubicin-induced epithelial-mesenchymal transition via inhibition of ERK signaling pathways in hepatocellular carcinoma

Doxorubicin (DOX) is a conventional and effective chemotherapeutic used in the treatment of hepatocellular carcinoma (HCC). However, doxorubicin administration may induce EMT, which results in the development of chemoresistance in HCC. Recent studies report that Isocorydine (ICD) selectively inhibit...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Am J Cancer Res
Huvudupphovsmän: Pan, Jie-Xue, Chen, Gang, Li, Jun-Jian, Zhu, Qian-Dong, Li, Jing-Jie, Chen, Zong-Jing, Yu, Zheng-Ping, Ye, Long-Yun
Materialtyp: Artigo
Språk:Inglês
Publicerad: e-Century Publishing Corporation 2018
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5794729/
https://ncbi.nlm.nih.gov/pubmed/29416928
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk